Skip to main content
Top
Published in: Abdominal Radiology 5/2018

01-05-2018

Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer

Authors: Elmira Hassanzadeh, Francesco Alessandrino, Olutayo I. Olubiyi, Daniel I. Glazer, Robert V. Mulkern, Andriy Fedorov, Clare M. Tempany, Fiona M. Fennessy

Published in: Abdominal Radiology | Issue 5/2018

Login to get access

Abstract

Purpose

To compare diagnostic performance of PI-RADSv2 with ADC parameters to identify clinically significant prostate cancer (csPC) and to determine the impact of csPC definitions on diagnostic performance of ADC and PI-RADSv2.

Methods

We retrospectively identified treatment-naïve pathology-proven peripheral zone PC patients who underwent 3T prostate MRI, using high b-value diffusion-weighted imaging from 2011 to 2015. Using 3D slicer, areas of suspected tumor (T) and normal tissue (N) on ADC (b = 0, 1400) were outlined volumetrically. Mean ADCT, mean ADCN, ADCratio (ADCT/ADCN) were calculated. PI-RADSv2 was assigned. Three csPC definitions were used: (A) Gleason score (GS) ≥ 4 + 3; (B) GS ≥ 3 + 4; (C) MRI-based tumor volume >0.5 cc. Performances of ADC parameters and PI-RADSv2 in identifying csPC were measured using nonparametric comparison of receiver operating characteristic curves using the area under the curve (AUC).

Results

Eighty five cases met eligibility requirements. Diagnostic performances (AUC) in identifying csPC using three definitions were: (A) ADCT (0.83) was higher than PI-RADSv2 (0.65, p = 0.006); (B) ADCT (0.86) was higher than ADCratio (0.68, p < 0.001), and PI-RADSv2 (0.70, p = 0.04); (C) PI-RADSv2 (0.73) performed better than ADCratio (0.56, p = 0.02). ADCT performance was higher when csPC was defined by A or B versus C (p = 0.038 and p = 0.01, respectively). ADCratio performed better when csPC was defined by A versus C (p = 0.01). PI-RADSv2 performance was not affected by csPC definition.

Conclusions

When csPC was defined by GS, ADC parameters provided better csPC discrimination than PI-RADSv2, with ADCT providing best result. When csPC was defined by MRI-calculated volume, PI-RADSv2 provided better discrimination than ADCratio. csPC definition did not affect PI-RADSv2 diagnostic performance.
Literature
1.
go back to reference Miller KD, Siegel RL, Lin CC, et al. (2016) Cancer treatment and survivorship statistics. CA Cancer J Clin 66(4):271–289CrossRefPubMed Miller KD, Siegel RL, Lin CC, et al. (2016) Cancer treatment and survivorship statistics. CA Cancer J Clin 66(4):271–289CrossRefPubMed
3.
go back to reference Etzioni R, Penson DF, Legler JM, et al. (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94(13):981–990CrossRefPubMed Etzioni R, Penson DF, Legler JM, et al. (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94(13):981–990CrossRefPubMed
4.
go back to reference Ahmed HU, Hu Y, Carter T, et al. (2011) Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol 186(2):458–464CrossRefPubMed Ahmed HU, Hu Y, Carter T, et al. (2011) Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol 186(2):458–464CrossRefPubMed
5.
go back to reference Rasiah KK, Stricker PD, Haynes A-M, et al. (2003) Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98(12):2560–2565CrossRefPubMed Rasiah KK, Stricker PD, Haynes A-M, et al. (2003) Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98(12):2560–2565CrossRefPubMed
6.
go back to reference Wolters T, Roobol MJ, van Leeuwen PJ, et al. (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125CrossRefPubMed Wolters T, Roobol MJ, van Leeuwen PJ, et al. (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125CrossRefPubMed
7.
go back to reference Kumar V, Jagannathan NR, Kumar R, et al. (2007) Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed 20(5):505–511CrossRefPubMed Kumar V, Jagannathan NR, Kumar R, et al. (2007) Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed 20(5):505–511CrossRefPubMed
8.
go back to reference Woo S, Kim SY, Cho JY, et al. (2016) Preoperative evaluation of prostate cancer aggressiveness: using ADC and ADC ratio in determining Gleason score. AJR 207(1):114–120CrossRefPubMed Woo S, Kim SY, Cho JY, et al. (2016) Preoperative evaluation of prostate cancer aggressiveness: using ADC and ADC ratio in determining Gleason score. AJR 207(1):114–120CrossRefPubMed
9.
go back to reference Hambrock T, Somford DM, Huisman HJ, et al. (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259(2):453–461CrossRefPubMed Hambrock T, Somford DM, Huisman HJ, et al. (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259(2):453–461CrossRefPubMed
10.
go back to reference Vargas HA, Akin O, Franiel T, et al. (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259(3):775–784CrossRefPubMedPubMedCentral Vargas HA, Akin O, Franiel T, et al. (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259(3):775–784CrossRefPubMedPubMedCentral
11.
go back to reference Metens T, Miranda D, Absil J, et al. (2012) What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22(3):703–709CrossRefPubMed Metens T, Miranda D, Absil J, et al. (2012) What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22(3):703–709CrossRefPubMed
12.
go back to reference Kim CK, Park BK (2010) Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR 194(1):W33–W37CrossRefPubMed Kim CK, Park BK (2010) Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR 194(1):W33–W37CrossRefPubMed
13.
go back to reference Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS prostate imaging—reporting and data system: 2015, version 2. Eur Urol 69(1):16–40CrossRefPubMed Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS prostate imaging—reporting and data system: 2015, version 2. Eur Urol 69(1):16–40CrossRefPubMed
14.
go back to reference Bratan F, Niaf E, Melodelima C, et al. (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23(7):2019–2029CrossRefPubMed Bratan F, Niaf E, Melodelima C, et al. (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23(7):2019–2029CrossRefPubMed
15.
go back to reference Jambor I, Boström PJ, Taimen P, et al. (2017) Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial). J Magn Reson Imaging. doi:10.1002/jmri.25641 Jambor I, Boström PJ, Taimen P, et al. (2017) Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial). J Magn Reson Imaging. doi:10.​1002/​jmri.​25641
16.
go back to reference Ahmed HU, El-Shater Bosaily A, Brown LC, et al. (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed Ahmed HU, El-Shater Bosaily A, Brown LC, et al. (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed
17.
go back to reference Kozlowski P, Chang SD, Goldenberg SL (2008) Diffusion-weighted MRI in prostate cancer—comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging 26(1):72–76CrossRefPubMed Kozlowski P, Chang SD, Goldenberg SL (2008) Diffusion-weighted MRI in prostate cancer—comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging 26(1):72–76CrossRefPubMed
19.
go back to reference McNeal JE, Redwine EA, Freiha FS, et al. (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906CrossRefPubMed McNeal JE, Redwine EA, Freiha FS, et al. (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906CrossRefPubMed
20.
go back to reference Vargas HA, Hötker AM, Goldman DA, et al. (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26(6):1606–1612CrossRefPubMed Vargas HA, Hötker AM, Goldman DA, et al. (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26(6):1606–1612CrossRefPubMed
21.
go back to reference Hegde JV, Mulkern RV, Panych LP, et al. (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5):1035–1054CrossRefPubMedPubMedCentral Hegde JV, Mulkern RV, Panych LP, et al. (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5):1035–1054CrossRefPubMedPubMedCentral
22.
go back to reference Srigley JR, Humphrey PA, Amin MB, et al. (2009) Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 133(10):1568–1576PubMed Srigley JR, Humphrey PA, Amin MB, et al. (2009) Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 133(10):1568–1576PubMed
23.
go back to reference Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30(9):1323–1341CrossRefPubMedPubMedCentral Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30(9):1323–1341CrossRefPubMedPubMedCentral
24.
go back to reference Fedorov A, Vangel MG, Tempany CM, Fennessy FM (2017) Multiparametric magnetic resonance imaging of the prostate: repeatability of volume and apparent diffusion coefficient quantification. Investig Radiol 52(9):538–546CrossRef Fedorov A, Vangel MG, Tempany CM, Fennessy FM (2017) Multiparametric magnetic resonance imaging of the prostate: repeatability of volume and apparent diffusion coefficient quantification. Investig Radiol 52(9):538–546CrossRef
25.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRefPubMed
26.
go back to reference Stensland KD, Coutinho K, Hobbs AR, et al. (2016) Are magnetic resonance imaging undetectable prostate tumours clinically significant? Results of histopathological analyses. Arab J Urol 14(4):256–261CrossRefPubMedPubMedCentral Stensland KD, Coutinho K, Hobbs AR, et al. (2016) Are magnetic resonance imaging undetectable prostate tumours clinically significant? Results of histopathological analyses. Arab J Urol 14(4):256–261CrossRefPubMedPubMedCentral
27.
go back to reference Truong M, Hollenberg G, Weinberg E, et al. (2017) Impact of Gleason subtype on prostate cancer detection using multiparametric MRI: correlation with final histopathology. J Urol. doi:10.1016/j.juro.2017.01.077 Truong M, Hollenberg G, Weinberg E, et al. (2017) Impact of Gleason subtype on prostate cancer detection using multiparametric MRI: correlation with final histopathology. J Urol. doi:10.​1016/​j.​juro.​2017.​01.​077
28.
29.
go back to reference Priester A, Natarajan S, Khoshnoodi P, et al. (2017) Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol 197(2):320–326CrossRefPubMed Priester A, Natarajan S, Khoshnoodi P, et al. (2017) Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol 197(2):320–326CrossRefPubMed
30.
go back to reference Zhao C, Gao G, Fang D, et al. (2016) The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS version 2 in the diagnosis of clinically significant prostate cancer. Clin Imaging 40(5):885–888CrossRefPubMed Zhao C, Gao G, Fang D, et al. (2016) The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS version 2 in the diagnosis of clinically significant prostate cancer. Clin Imaging 40(5):885–888CrossRefPubMed
31.
go back to reference Lin WC, Westphalen AC, Silva GE, et al. (2016) Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer. Abdom Radiol (NY) 41(11):2209–2217CrossRef Lin WC, Westphalen AC, Silva GE, et al. (2016) Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer. Abdom Radiol (NY) 41(11):2209–2217CrossRef
32.
go back to reference Glazer DI, Hassanzadeh E, Fedorov A, et al. (2017) Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology. Abdom Radiol (NY) 42(3):918–925CrossRefPubMedCentral Glazer DI, Hassanzadeh E, Fedorov A, et al. (2017) Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology. Abdom Radiol (NY) 42(3):918–925CrossRefPubMedCentral
33.
go back to reference Donati OF, Mazaheri Y, Afaq A, et al. (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271(1):143–152CrossRefPubMed Donati OF, Mazaheri Y, Afaq A, et al. (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271(1):143–152CrossRefPubMed
34.
go back to reference Lebovici A, Sfrangeu SA, Feier D, et al. (2014) Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness. BMC Med Imaging 14:15CrossRefPubMedPubMedCentral Lebovici A, Sfrangeu SA, Feier D, et al. (2014) Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness. BMC Med Imaging 14:15CrossRefPubMedPubMedCentral
35.
go back to reference Boesen L, Chabanova E, Løgager V, et al. (2015) Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. J Magn Reson Imaging 42(2):446–453CrossRefPubMed Boesen L, Chabanova E, Løgager V, et al. (2015) Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. J Magn Reson Imaging 42(2):446–453CrossRefPubMed
36.
go back to reference Jones AC, Antillon KS, Jenkins SM, et al. (2015) Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. PLoS One 10(3):e0119314CrossRefPubMedPubMedCentral Jones AC, Antillon KS, Jenkins SM, et al. (2015) Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. PLoS One 10(3):e0119314CrossRefPubMedPubMedCentral
37.
go back to reference Mulkern RV, Barnes AS, Haker SJ, et al. (2006) Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 24(5):563–568CrossRefPubMedPubMedCentral Mulkern RV, Barnes AS, Haker SJ, et al. (2006) Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 24(5):563–568CrossRefPubMedPubMedCentral
38.
go back to reference Agarwal HK, Mertan FV, Sankineni S, et al. (2017) Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging 45(1):125–131CrossRefPubMed Agarwal HK, Mertan FV, Sankineni S, et al. (2017) Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging 45(1):125–131CrossRefPubMed
39.
go back to reference Ukimura O, Coleman JA, de la Taille A, et al. (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63(2):214–230CrossRefPubMed Ukimura O, Coleman JA, de la Taille A, et al. (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63(2):214–230CrossRefPubMed
40.
go back to reference Purysko AS, Bittencourt LK, Bullen JA, et al. (2017) Accuracy and interobserver agreement for prostate imaging reporting and data system, version 2, for the characterization of lesions identified on multiparametric MRI of the prostate. AJR 209(2):339–349CrossRefPubMed Purysko AS, Bittencourt LK, Bullen JA, et al. (2017) Accuracy and interobserver agreement for prostate imaging reporting and data system, version 2, for the characterization of lesions identified on multiparametric MRI of the prostate. AJR 209(2):339–349CrossRefPubMed
Metadata
Title
Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer
Authors
Elmira Hassanzadeh
Francesco Alessandrino
Olutayo I. Olubiyi
Daniel I. Glazer
Robert V. Mulkern
Andriy Fedorov
Clare M. Tempany
Fiona M. Fennessy
Publication date
01-05-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1297-y

Other articles of this Issue 5/2018

Abdominal Radiology 5/2018 Go to the issue

Classics in Abdominal Imaging

The bowler hat sign